Pharmaceutical Preparations Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Pharmaceutical Preparations
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
100 results. Finviz
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company Name

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2024-02-20
KALVKalvista Pharmaceuticals, Inc.Feener Edward P.Chief Scientific OfficerS - Sale+OE$14.07-28,28862,157-31%-$397,929
D
2024-02-20
KALVKalvista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerS - Sale+OE$14.11-12,05372,895-14%-$170,124
D
2024-02-20
KALVKalvista Pharmaceuticals, Inc.Palleiko Benjamin LCFO, CBOS - Sale+OE$14.11-22,802187,315-11%-$321,846
D
2024-02-20
KALVKalvista Pharmaceuticals, Inc.Audhya Paul K.Chief Medical OfficerS - Sale+OE$14.12-14,29552,886-21%-$201,774
D
2024-02-20
KALVKalvista Pharmaceuticals, Inc.Crockett Thomas AndrewCEOS - Sale+OE$14.11-24,888211,203-11%-$351,289
D
2024-02-16
CORTCorcept Therapeutics IncLyon Joseph DouglasChief Accounting OfficerS - Sale+OE$26.00-1,0006,774-13%-$26,000
D
2024-02-16
RCKTRocket Pharmaceuticals, Inc.Wilson MartinGCS - Sale+OE$29.84-3,57622,780-14%-$106,701
D
2024-02-16
RCKTRocket Pharmaceuticals, Inc.Patel KinnariSee RemarksS - Sale+OE$29.84-7,132378,903-2%-$212,805
D
2024-02-16
RCKTRocket Pharmaceuticals, Inc.Militello JohnSee RemarksS - Sale+OE$29.84-3,23821,517-13%-$96,615
D
2024-02-16
RCKTRocket Pharmaceuticals, Inc.Shah GauravCEOS - Sale+OE$29.84-20,2721,027,577-2%-$604,876
2024-02-20
TNGXTango Therapeutics, Inc.Third Rock Ventures Iv, L.P.10%S - Sale$12.00-162,50019,201,475-1%-$1,950,000
D
2024-02-16
ANABAnaptysbio, IncLoumeau Eric JGCS - Sale+OE$25.00-5,0003,240-61%-$125,000
2024-02-21
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$0.99+1,000,000241,564,3530%+$991,700
2024-02-13
NAMSNewamsterdam Pharma Co N.V.Lange Louis GDirP - Purchase$19.00+5,00024,878+25%+$95,000
2024-02-20
ETSTEarth Science Tech, Inc.Saumat Giorgio R.CEO, 10%P - Purchase$0.08+60,000119,577,4070%+$4,740
2024-02-16
ETSTEarth Science Tech, Inc.Sanchez Yovan ArturoDirP - Purchase$0.07+50,000550,000+10%+$3,500
2024-02-20
VRTXVertex Pharmaceuticals Inc / MaTatsis OuraniaEVP, Chief Reg., Quality OfficS - Sale$420.79-48059,827-1%-$201,979
D
2024-02-20
ZTSZoetis Inc.Peck Kristin CCEOS - Sale+OE$187.20-13,00080,160-14%-$2,433,636
2024-02-20
ZTSZoetis Inc.Lagano RoxanneEVPS - Sale$187.30-92317,440-5%-$172,878
2024-02-20
VRTXVertex Pharmaceuticals Inc / MaSachdev AmitEVP Chief Patient, Ext Af OffS - Sale$420.79-4,25471,436-6%-$1,790,041
D
2024-02-20
ANNXAnnexon, Inc.Lew JenniferEVP, CFOS - Sale+OE$5.53-2,59382,058-3%-$14,339
D
2024-02-20
ANNXAnnexon, Inc.Yednock TedEVP, CHIEF INNOVATION OFFICERS - Sale+OE$5.51-2,60493,471-3%-$14,348
D
2024-02-20
ANNXAnnexon, Inc.Overdorf MichaelEVP, CHIEF BUSINESS OFFICERS - Sale+OE$5.48-1,95185,641-2%-$10,691
2024-02-20
VRTXVertex Pharmaceuticals Inc / MaAtkinson Edward Morrow IIIEVP, Chief Technical Ops. OffiS - Sale$420.79-80119,710-4%-$337,053
2024-02-20
VRTXVertex Pharmaceuticals Inc / MaArbuckle Stuart AEVP, COOS - Sale$420.79-4,80463,182-7%-$2,021,475
2024-02-20
VRTXVertex Pharmaceuticals Inc / MaAltshuler DavidEVP, Global Research, CSOS - Sale$420.79-4,00237,024-10%-$1,684,002
2024-02-16
MRNSMarinus Pharmaceuticals, Inc.Hulihan JosephCHIEF MEDICAL OFFICERS - Sale$9.98-2,81466,635-4%-$28,084
2024-02-16
MRNSMarinus Pharmaceuticals, Inc.Pfanstiel StevenCFO, COOS - Sale$9.97-3,09271,697-4%-$30,827
2024-02-16
MRNSMarinus Pharmaceuticals, Inc.Braunstein ScottCOB, CEOS - Sale$9.94-11,850223,512-5%-$117,789
2024-02-20
INMInmed Pharmaceuticals Inc.Adams Eric APres, CEOP - Purchase$0.36+41,60043,959>999%+$14,922
2024-02-16
RZLTRezolute, Inc.Roberts Brian KennethChief Medical OfficerP - Purchase$1.31+7,00034,552+25%+$9,142
2024-02-16
TEVATeva Pharmaceutical Industries LtdDrape EricEVP Global OperationsS - Sale$13.05-173,2611-100%-$2,261,905
2024-02-16
GLSIGreenwich Lifesciences, Inc.Patel SnehalCEO, CFO, 10%P - Purchase$11.16+10,8005,336,1770%+$120,528
DM
2024-02-15
CORTCorcept Therapeutics IncMaduck SeanSee RemarksS - Sale+OE$25.82-31,82894,455-25%-$821,905
2024-02-15
ELVNEnliven Therapeutics, Inc.Heyman Richard A.DirS - Sale$17.42-1,270211,363-1%-$22,117
D
2024-02-16
DAWNDay One Biopharmaceuticals, Inc.Dubow AdamGCS - Sale+OE$15.25-3,24216,585-16%-$49,434
M
2024-02-15
MLTXMoonlake ImmunotherapeuticsSantos Da Silva JorgeCEOS - Sale$59.26-60,0003,107,554-2%-$3,555,400
M
2024-02-15
DYNDyne Therapeutics, Inc.Rhodes Jason PDirS - Sale$23.26-510,1529,359,331-5%-$11,867,292
D
2024-02-16
DAWNDay One Biopharmaceuticals, Inc.York Charles N IICOO, CFO, SecretaryS - Sale+OE$15.25-2,666277,754-1%-$40,651
M
2024-02-15
DYNDyne Therapeutics, Inc.Atlas Venture Fund Xi, L.P.10%S - Sale$23.26-510,1526,815,965-7%-$11,867,292
D
2024-02-16
DAWNDay One Biopharmaceuticals, Inc.Blackman Samuel C.Head of Research, DevelopmeS - Sale+OE$15.25-2,2582,244,6620%-$34,430
D
2024-02-16
DAWNDay One Biopharmaceuticals, Inc.Bender JeremyCEOS - Sale+OE$15.25-7,6151,765,5370%-$116,114
2024-02-15
FOLDAmicus Therapeutics, Inc.Crowley John FExec COBS - Sale$13.81-31,614667,554-5%-$436,551
2024-02-15
FOLDAmicus Therapeutics, Inc.Campbell Bradley LPres, CEOS - Sale$14.00-4,167871,2190%-$58,338
2024-02-15
FOLDAmicus Therapeutics, Inc.Clark David MichaelChief People OfficerS - Sale$14.00-4,427253,664-2%-$61,978
2024-02-15
MNKTQMallinckrodt PlcGoldentree Asset Management LP10%P - Purchase$38.25+225,0002,316,035+11%+$8,606,250
2024-02-15
KPTIKaryopharm Therapeutics Inc.Poulton StuartEVP, Chief Development OfficerS - Sale$1.33-5,847163,772-3%-$7,783
2024-02-15
TRDAEntrada Therapeutics, Inc.Doshi DipalCEOS - Sale$15.00-1,000243,2790%-$15,000
2024-02-16
ALNYAlnylam Pharmaceuticals, Inc.Garg PushkalCMO, EVP Dev, Med AffairsS - Sale$148.06-1,3088,013-14%-$193,666
2024-02-16
ALNYAlnylam Pharmaceuticals, Inc.Poulton Jeffrey V.EVP, CFOS - Sale$148.06-1,00718,201-5%-$149,099
2024-02-16
ALNYAlnylam Pharmaceuticals, Inc.Tanguler TolgaEVP, Chief Commercial OfficerS - Sale$148.06-1,0094,070-20%-$149,397
2024-02-16
ALNYAlnylam Pharmaceuticals, Inc.Greenstreet YvonneCEOS - Sale$148.06-7,03045,546-13%-$1,040,885
D
2024-02-16
DCPHDeciphera Pharmaceuticals, Inc.Sherman Matthew LEVP, Chief Medical OfficerS - Sale+OE$15.62-2,615108,739-2%-$40,840
D
2024-02-16
DCPHDeciphera Pharmaceuticals, Inc.Kelly Thomas PatrickCFOS - Sale+OE$15.62-3,01080,350-4%-$47,009
2024-02-16
LLYEli Lilly & CoLilly Endowment Inc10%S - Sale$780.99-169,68498,898,8100%-$132,521,930
D
2024-02-16
DCPHDeciphera Pharmaceuticals, Inc.Pitman JamaSVP, Chief Development OfficerS - Sale+OE$15.62-2,26768,031-3%-$35,405
D
2024-02-16
DCPHDeciphera Pharmaceuticals, Inc.Martin Daniel C.Chief Commercial OfficerS - Sale+OE$15.62-2,26755,118-4%-$35,405
D
2024-02-15
BBIOBridgebio Pharma, Inc.Valantine HannahDirS - Sale+OE$37.75-2,9155,197-36%-$110,041
D
2024-02-15
PBHPrestige Consumer Healthcare Inc.Mekhail AdelEVP, Marketing, SalesS - Sale+OE$69.11-15,54918,681-45%-$1,074,645
D
2024-02-15
TEVATeva Pharmaceutical Industries LtdFrancis Richard DPres, CEOS - Sale+OE$13.15-74,53087,125-46%-$980,174
2024-02-16
RZLTRezolute, Inc.Evans DaronCFOP - Purchase$1.31+50,90089,900+131%+$66,741
2024-02-15
GLSIGreenwich Lifesciences, Inc.Patel SnehalCEO, CFO, 10%P - Purchase$11.07+12,7005,325,3770%+$140,589
D
2024-02-16
MCRBSeres Therapeutics, Inc.Desrosier ThomasGC, EVPS - Sale+OE$1.08-3,939120,577-3%-$4,254
D
2024-02-16
MCRBSeres Therapeutics, Inc.Shaff Eric D.CEO, PresS - Sale+OE$1.08-11,549135,321-8%-$12,473
D
2024-02-16
MCRBSeres Therapeutics, Inc.Henn Matthew R.See RemarksS - Sale+OE$1.08-4,17063,436-6%-$4,504
D
2024-02-16
MCRBSeres Therapeutics, Inc.Young Teresa L.See RemarksS - Sale+OE$1.08-3,37415,705-18%-$3,644
D
2024-02-16
MCRBSeres Therapeutics, Inc.Von Moltke LisaSee RemarksS - Sale+OE$1.08-4,40016,988-21%-$4,752
D
2024-02-16
MCRBSeres Therapeutics, Inc.Ege David S.See RemarksS - Sale+OE$1.08-5,01073,856-6%-$5,411
D
2024-02-16
MCRBSeres Therapeutics, Inc.Arkowitz DavidCFOS - Sale+OE$1.08-3,939182,442-2%-$4,254
2024-02-14
CMRXChimerix IncAndriole Michael T.Pres, CEOS - Sale$1.04-1,744447,0210%-$1,809
2024-02-14
CMRXChimerix IncLaspaluto MichelleCFOS - Sale$1.04-1,940110,999-2%-$2,023
2024-02-14
CMRXChimerix IncJakeman DavidVP of Finance, AccountingS - Sale$1.04-2,660141,232-2%-$2,777
2024-02-16
IONSIonis Pharmaceuticals IncMonia Brett PCEOS - Sale$44.49-387173,7510%-$17,219
2024-02-16
NRIXNurix Therapeutics, Inc.Van Houte HansCFOS - Sale$10.02-6,81268,333-9%-$68,223
M
2024-02-14
MLTXMoonlake ImmunotherapeuticsReich KristianChief Scientific OfficerS - Sale$60.91-60,0003,107,554-2%-$3,654,800
2024-02-15
VTRSViatris IncCuneo AndrewSee RemarksS - Sale$12.50-4,00038,795-9%-$50,000
D
2024-02-15
ME23Andme Holding Co.Hibbs Kathy LChief Administrative OfficerS - Sale+OE$0.78-38,5481,280,349-3%-$30,210
2024-02-14
KALVKalvista Pharmaceuticals, Inc.Palleiko Benjamin LCFO, CBOS - Sale$15.01-40,855159,088-20%-$613,205
2024-02-14
KALVKalvista Pharmaceuticals, Inc.Crockett Thomas AndrewCEOS - Sale$15.01-58,356181,676-24%-$875,883
2024-02-14
KALVKalvista Pharmaceuticals, Inc.Feener Edward P.Chief Scientific OfficerS - Sale$15.01-28,17171,657-28%-$422,827
2024-02-14
KALVKalvista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerS - Sale$15.01-39,88666,160-38%-$598,661
2024-02-14
REGNRegeneron Pharmaceuticals, Inc.Van Plew Daniel PEVP, General Mgr, IndustrialS - Sale$942.28-10,43433,838-24%-$9,831,727
2024-02-14
ELVNEnliven Therapeutics, Inc.5Am Partners Vi, LLC10%S - Sale$14.90-825,0003,835,975-18%-$12,292,500
M
2024-02-14
VRTXVertex Pharmaceuticals Inc / MaLeiden Jeffrey MExec COBS - Sale$419.10-9,01118,336-33%-$3,776,528
2024-02-15
LLYEli Lilly & CoLilly Endowment Inc10%S - Sale$760.46-50,31699,068,4940%-$38,263,417
D
2024-02-14
PBHPrestige Consumer Healthcare Inc.Sacco ChristineCFOS - Sale+OE$68.35-30,01921,738-58%-$2,051,874
D
2024-02-15
ALKSAlkermes Plc.Laurencin Cato TDirS - Sale+OE$31.85-2,69015,169-15%-$85,677
D
2024-02-14
PBHPrestige Consumer Healthcare Inc.P'Pool WilliamSee RemarksS - Sale+OE$67.90-26,01924,917-51%-$1,766,665
2024-02-16
LRMRLarimar Therapeutics, Inc.Flynn James E* Director by Deputization, 10%P - Purchase$8.74+4,290,61721,231,974+25%+$37,499,993
2024-02-13
AZTRAzitra, Inc.Whitfill TravisCOOP - Purchase$0.30+15,000334,500+5%+$4,500
2024-02-13
AZTRAzitra, Inc.Staskey NormCFOP - Purchase$0.30+3,3003,500>999%+$990
2024-02-13
AZTRAzitra, Inc.Salva Francisco D.Pres, CEOP - Purchase$0.30+333,300338,300>999%+$99,990
M
2024-02-13
RYTMRhythm Pharmaceuticals, Inc.Shulman JosephChief Technical OfficerS - Sale$50.00-2,95430-99%-$147,711
D
2024-01-09
FIXXHomology Medicines, Inc.Tzianabos ArthurDirS - Sale+OE$0.57-13,037128,778-9%-$7,445
D
2024-02-15
UTHRUnited Therapeutics CorpMahon Paul AEVP, GCS - Sale+OE$215.31-6,00036,599-14%-$1,291,885
2024-02-14
LRMRLarimar Therapeutics, Inc.Thomas Frank EDirP - Purchase$11.00+2,0002,000New+$22,000
D
2024-02-13
TELOTelomir Pharmaceuticals, Inc.Bay Shore Trust10%P - Purchase$7.00+138,0003,292,696+4%+$966,000
M
2023-12-04
BSPKBespoke Extracts, Inc.Feinsod MichaelCEO, 10%P - Purchase$0.06+96,5002,120,112+5%+$5,710
D
2024-02-14
MRKMerck & Co., Inc.Litchfield CarolineEVP, CFOS - Sale+OE$125.50-38,29150,908-43%-$4,805,521
2024-02-13
XNCRXencor IncGorman Kevin CharlesDirP - Purchase$19.12+535,060+1%+$1,013

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top